Theriva Biologics, Inc. (TOVX) — Analyst estimates
Consensus analyst estimates for Theriva Biologics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 300K | -0.06 | 1 |
| 2027 | 300K | -0.06 | 1 |
| 2028 | 25.73M | -0.32 | 1 |
| 2029 | 54.05M | -0.37 | 1 |
| 2030 | 154.4M | -0.43 | 1 |
Consensus analyst estimates by fiscal year.